Global medical cannabis research and patient outcomes

Research and clinical studies throughout 2026 have examined the efficacy and challenges of medical cannabis use for various conditions.

In Australia, qualitative studies indicate that long-term users utilize cannabis oil to manage chronic pain, insomnia, anxiety, and depression, often allowing them to reduce conventional medication. However, patients face barriers such as high costs and prescription difficulties. A clinical trial for an Australian-made CBD tablet showed the product was safe and provided some immediate improvement, though it failed to outperform a placebo in meeting primary trial goals.

Broader international research has highlighted significant therapeutic benefits. A large-scale study in Minnesota involving over 6,600 patients found that medical cannabis helped cancer patients manage pain, nausea, vomiting, anxiety, and depression while improving sleep quality. In the UK, a study of 698 patients linked cannabis-based medicinal products to sustained improvements in mental health and sleep over two years. Additionally, trials involving recreational runners suggested that CBD can increase feelings of calmness and reduce perceived exertion during exercise.